Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TTR | P02766 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29486360 | 1.00 | TDP1 (0.64) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL28661794 | 0.98 | TDP1 (0.62) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL28107243 | 0.98 | TDP1 (0.62) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL29087916 | 0.89 | TDP1 (0.53) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL8815813 | 0.88 | TDP1 (0.51) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL5495526 | 0.85 | ALDH1A1 (0.51) | TDP1ATMGPR35TTRMAPT | |
| SCHEMBL229093 | 0.83 | MAPK1 (0.62) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL28287904 | 0.82 | MAPK1 (0.60) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL29745239 | 0.80 | TDP1 (0.72) | TDP1ATMGPR35HPGDCYP3A4 | |
| SCHEMBL216553 | 0.80 | TDP1 (0.72) | TDP1ATMGPR35HPGDCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117362284-B | Flumioxazin and its preparation method Process for the preparation of amines | 厦门大学 | 2026-05-12 | — | — | CN | claimed |
| CN-116143768-B | Benzoxazinone compound containing thioquinazolinone ring as well as preparation method and application thereof | 浙江工业大学 | 2025-06-24 | — | — | CN | claimed |
| CN-116514662-B | Preparation method of 5-fluoro-2-nitrophenol | 山东京博农化科技股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119500034-A | Dynamic tubular reactor and process for preparing flumioxazin | 甘肃联凯生物科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-116655554-B | Green synthesis method of flumioxazin key intermediate | 浙江南郊化学有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-116082267-B | 6-Substituted flumioxazin compound as well as preparation method and application thereof | 浙江工业大学 | 2024-10-11 | — | — | CN | claimed |
| CN-116178300-B | Benzoxazinone compound containing diphenyl ether structure and preparation method and application thereof | 浙江工业大学 | 2024-09-17 | — | — | CN | claimed |
| CN-116082325-B | Benzoxazinone compound containing isoxazole heterocycle, and preparation method and application thereof | 浙江工业大学 | 2024-04-16 | — | — | CN | claimed |
| CN-117378617-A | Flumioxazin herbicide and preparation method thereof | 甘肃联凯生物科技有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-117362284-A | Preparation method of flumioxazin | 厦门大学 | 2024-01-09 | — | — | CN | claimed |
| CN-106083536-A | A kind of preparation method of the bent key intermediate in Ansai | 浙江永太科技股份有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-106045861-A | Method and system for continuously producing 5-fluoro-2-nitrophenol | 山东润博生物科技有限公司 | 2016-10-26 | — | — | CN | claimed |
| CN-105837480-A | Preparation method for asymmetric aromatic thioether | 南京理工大学 | 2016-08-10 | — | — | CN | claimed |
| WO-2014122674-A1 | PROCESS FOR PREPARATION OF DERIVATIVES OF TETRAHYDROPHTHALIMIDE | RALLIS INDIA LIMITED (IN) | 2014-08-14 | — | — | WO | claimed |
| US-7365231-B2 | Compound with antitumor activity and preparation method therefor | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2008-04-29 | — | — | US | claimed |
| US-20060241187-A1 | Compound with antitumor activity and preparation method therefor | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2006-10-26 | — | — | US | claimed |
| CN-1207269-C | 1,3,5-tri(3-hydroxy-4-aminophenoxy)benzene and its hydrochlorides and preparation thereof | UNIV SHANGHAI JIAOTONG (CN) | 2005-06-22 | — | — | CN | claimed |
| CN-1203048-C | 3,5-bi(3-hydroxy-4-aminophenoxy)benzoic acid and its hydrochlorides and preparation thereof | UNIV SHANGHAI COMMUNICATION (CN) | 2005-05-25 | — | — | CN | claimed |
| CN-1472191-A | 1,3,5-tri(3-hydroxy-4-aminophenoxy)benzene and its hydrochlorides and preparation thereof | 上海交通大学 | 2004-02-04 | — | — | CN | claimed |
| CN-1472192-A | 3,5-bi(3-hydroxy-4-aminophenoxy)benzoic acid and its hydrochlorides and preparation thereof | 上海交通大学 | 2004-02-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241187-A1 | Compound with antitumor activity and preparation method therefor | WEE1, WEE2, CYP51A1 | TDP1 617/4885ATM 4595/4885GPR35 2929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.